Differential patterns of T-cell receptor BV-specific activation of T cells by gp 120 from different HIV strains

被引:4
作者
Akolkar, PN [1 ]
GulwaniAkolkar, B [1 ]
Silver, J [1 ]
机构
[1] N SHORE UNIV HOSP,CORNELL UNIV MED COLL,DEPT MED,DIV MOLEC MED,MANHASSET,NY 11030
关键词
D O I
10.1111/j.1365-3083.1995.tb03702.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies by several groups have suggested that HIV infection in vivo results in a BV-specific alteration of the TCR repertoire and that this might play a role in the pathogenesis of AIDS. Our earlier studies demonstrated that both a crude extract of HIV451 as well as purified gp160 from HIV451 could specifically activate, in vitro, T cells expressing a common set of TCRBV segments (TCRBV3, 12, 14, 15, and sometimes BV17 and 20) in individuals of disparate HLA type. Furthermore, purified gp120 from HIV451 was shown to have a similar ability to activate T cells, although with a slightly different TCRBV-specific pattern. In order to determine whether gp120 from other HIV strains could similarly activate T cells in a TCRBV-specific pattern, PBMC from HIV seronegative individuals of disparate HLA type were stimulated with gp120 from three strains of HIV (451, IIIB, and MN). The authors found that gp120 from all three strains activate T cells bearing TCRBV2 and BV3 in nearly every individual. T cells expressing other BV segments are also activated, but this is more variable and appears to be unique to each individual. Furthermore, gp120(451) and gp120 from HIVIIIB and HIVMN differ in their ability to activate T cells expressing these other TCRBV segments. These observations suggest that variation in the structure of gp120 and in the genetic and/or environmental background of the individual play an important role in determining which TCRBV segments are 'triggered' by gp120. Furthermore, these observations may have important implications for the rate of disease progression in HIV-infected individuals.
引用
收藏
页码:598 / 606
页数:9
相关论文
共 35 条
[1]   THE HIV GLYCOPROTEIN GP160 HAS SUPERANTIGEN-LIKE PROPERTIES [J].
AKOLKAR, PN ;
GULWANIAKOLKAR, B ;
CHIRMULE, N ;
PAHWA, S ;
KALYANARAMAN, VS ;
PERGOLIZZI, R ;
MACPHAIL, S ;
SILVER, J .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 76 (03) :255-265
[2]   V-BETA-SPECIFIC ACTIVATION OF T-CELLS BY THE HIV GLYCOPROTEIN GP160 [J].
AKOLKAR, PN ;
CHIRMULE, N ;
GULWANIAKOLKAR, B ;
PAHWA, S ;
KALYANARAMAN, VS ;
PERGOLIZZI, R ;
MACPHAIL, S ;
SILVER, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (05) :487-498
[3]  
AKOLKAR PN, 1993, J IMMUNOL, V150, P2761
[4]   THE INFLUENCE OF NON-HLA GENES ON THE HUMAN T-CELL RECEPTOR REPERTOIRE [J].
AKOLKAR, PN ;
GULWANIAKOLKAR, B ;
ROBINSON, MA ;
SILVER, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 42 (02) :248-256
[5]   COMPARISONS OF T-CELL RECEPTOR (TCR) V-BETA REPERTOIRES OF LAMINA PROPRIA AND PERIPHERAL-BLOOD LYMPHOCYTES WITH RESPECT TO FREQUENCY AND OLIGOCLONALITY [J].
AKOLKAR, PN ;
GULWANIAKOLKAR, B ;
MCKINLEY, M ;
FISHER, SE ;
SILVER, J .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 76 (02) :155-163
[6]  
BANSAL AS, 1993, CLIN EXP IMMUNOL, V94, P17
[7]  
BOLOGNESI DP, 1990, MOL BIOL MED, V7, P1
[8]   INTERACTION OF STAPHYLOCOCCUS-AUREUS TOXIN SUPERANTIGENS WITH HUMAN T-CELLS [J].
CHOI, YW ;
KOTZIN, B ;
HERRON, L ;
CALLAHAN, J ;
MARRACK, P ;
KAPPLER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8941-8945
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]   RESPONSE OF NAIVE ANTIGEN-SPECIFIC CD4+ T-CELLS INVITRO - CHARACTERISTICS AND ANTIGEN-PRESENTING CELL REQUIREMENTS [J].
CROFT, M ;
DUNCAN, DD ;
SWAIN, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1431-1437